LFLizzy Farrugia

Lizzy Farrugia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lizzy Farrugia has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    medicX-KG: A Knowledge Graph for Pharmacists' Drug Information Needs

    by Lizzy Farrugia, Lilian M. Azzopardi, Jeremy Debattista, Charlie Abela

    The role of pharmacists is evolving from medicine dispensing to delivering comprehensive pharmaceutical services within multidisciplinary healthcare teams. Central to this shift is access to accurate, up-to-date medicinal product information supported by robust data integration. Leveraging artificial intelligence and semantic technologies, Knowledge Graphs (KGs) uncover hidden relationships and enable data-driven decision-making. This paper presents medicX-KG, a pharmacist-oriented knowledge graph supporting clinical and regulatory decisions. It forms the semantic layer of the broader medicX platform, powering predictive and explainable pharmacy services. medicX-KG integrates data from three sources, including, the British National Formulary (BNF), DrugBank, and the Malta Medicines Authority (MMA) that addresses Malta's regulatory landscape and combines European Medicines Agency alignment with partial UK supply dependence. The KG tackles the absence of a unified national drug repository, reducing pharmacists' reliance on fragmented sources. Its design was informed by interviews with practicing pharmacists to ensure real-world applicability. We detail the KG's construction, including data extraction, ontology design, and semantic mapping. Evaluation demonstrates that medicX-KG effectively supports queries about drug availability, interactions, adverse reactions, and therapeutic classes. Limitations, including missing detailed dosage encoding and real-time updates, are discussed alongside directions for future enhancements.

  • Open Access

    medicX-KE: A Knowledge Graph for Pharmacists’ Drug Information Needs

    by Lizzy Farrugia, Lilian M. Azzopardi, Jeremy Debattista, Charlie Abela

    The contribution of pharmacists to patient care is evolving from the traditional role of dispensing medicine to that of providing pharmaceutical services within a multidisciplinary healthcare context. An important component for this transformation towards a holistic patient-centric approach is the availability of relevant and up-to-date information about medicinal products that leverages a robust data collection mechanism. Over the past decade, Knowledge Graphs (KGs) have rev-olutionised the organisation and utilisation of vast biomedical data. Powered by Artificial Intelligence (AI) and advanced inferencing techniques, KGs unlock the potential to derive valuable insights, discover hidden relationships, and enable data-driven decision making. In this paper, we present the medicX-KE knowledge graph that is tailored to the Maltese pharmaceutical landscape. The KG serves as a centralised repository, integrating data from several authoritative sources, including DrugBank and the British National Formulary (BNF). We present a specific use case for our KG that relies on information related to medicine provided by the Malta Medicines Authority (MMA). In addition, we conducted interviews with six pharmacists to understand their needs and to obtain feedback on the suitability of the KG. We describe data acquisition, mappings, ontology design, construction, and evaluation of medicX-KE, and discuss the challenges faced and potential future enhancements.

  • Open Access

    Predicting Drug-Drug Interactions Using Knowledge Graphs

    by Lizzy Farrugia, Lilian M. Azzopardi, Jeremy Debattista, Charlie Abela

    In the last decades, people have been consuming and combining more drugs than before, increasing the number of Drug-Drug Interactions (DDIs). To predict unknown DDIs, recently, studies started incorporating Knowledge Graphs (KGs) since they are able to capture the relationships among entities providing better drug representations than using a single drug property. In this paper, we propose the medicX end-to-end framework that integrates several drug features from public drug repositories into a KG and embeds the nodes in the graph using various translation, factorisation and Neural Network (NN) based KG Embedding (KGE) methods. Ultimately, we use a Machine Learning (ML) algorithm that predicts unknown DDIs. Among the different translation and factorisation-based KGE models, we found that the best performing combination was the ComplEx embedding method with a Long Short-Term Memory (LSTM) network, which obtained an F1-score of 95.19% on a dataset based on the DDIs found in DrugBank version 5.1.8. This score is 5.61% better than the state-of-the-art model DeepDDI. Additionally, we also developed a graph auto-encoder model that uses a Graph Neural Network (GNN), which achieved an F1-score of 91.94%. Consequently, GNNs have demonstrated a stronger ability to mine the underlying semantics of the KG than the ComplEx model, and thus using higher dimension embeddings within the GNN can lead to state-of-the-art performance.